Alap: GLOGB
Global X Genomics & Biotechnology ETF (dis) | |
US37954Y4347 | |
05.04.2019 | |
Equity | |
Részvény Sectors - Health Care | |
Global X Funds | |
Global X Management Company LLC | |
USD | |
1 000 | |
5% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | -3.95% | -8.81% | -7.68% | -3.95% | -18.21% | -22.34% | -5.94% | - | - | N/A | |
Priemerná výkonnosť (36 meraní) | -1.71% | -16.11% | - | - | - | ||||||
Volatilita od priemernej výkonnosti | 13.82% | 38.16% | - | - | - |
Long | Short | Net | |
---|---|---|---|
Részvény | 99.92% | 99.92% | |
Kötvény | |||
Other | |||
Pénz piac | 0.08% | 0.08% |
Aktíva | 898 mil. |
Počet akcíí | 41 |
Počet dlhopisov | 0 |
Priebež. popl. | |
z toho Mng. popl. | 0.50 |
Výk. prémia | |
Trans. popl. |
Dividenda | 0.013 |
Dividendový výnos | 0.12% |
Rozhodný dátum | 30.12.2021 |
Frekvencia výplaty | polročne |
Giant | 0.00% |
Large | 7.67% |
Medium | 35.69% |
Small | 22.21% |
Micro | 34.34% |
P/E | 36.17% |
P/BV | 2.50% |
Healthcare | 99.92% |
Derivatives | 0.08 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
United States | 91.42% |
Canada | |
Latin America | |
United Kingdom | |
Eurozone | 4.18% |
Europe - ex Euro | 3.72% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | 0.60% |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 99.92% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Bio-Techne Corp | Healthcare | 4.86% | Moderna Inc | Healthcare | 4.5% |
Intellia Therapeutics Inc | Healthcare | 4.49% | Natera Inc | Healthcare | 4.29% |
Agilent Technologies Inc | Healthcare | 4.13% | Qiagen NV | Healthcare | 4.05% |
Myriad Genetics Inc | Healthcare | 3.96% | Arrowhead Pharmaceuticals Inc | Healthcare | 3.92% |
Sarepta Therapeutics Inc | Healthcare | 3.9% | Avidity Biosciences Inc Ordinary Shares | Healthcare | 3.83% |